KI1106

KI1106 · Kuhnil Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KI1106, covering 2018-11-19 to 2018-11-19. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Efficacy and Safety of KI1106 in Patients Whose TG Level is Not Adequately Controlled With Atorvastatin Calcium Monotherapy While LDL-C is Properly Controlled [Phase 3]

See pricing